Valuation (2%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -138.70 | -23.05 |
| PEG Ratio (TTM) | -7.98 | 15.47 |
| P/S Ratio (TTM) | N/A | 49.46 |
| P/B Ratio (TTM) | 38.85 | 18.87 |
| P/FCF Ratio (TTM) | -3.38 | -3.27 |
| Price to 5YR AVG Earnings Ratio | -4.99 | -3.55 |
| Price to 5YR AVG FCF Ratio | -6.82 | -9.37 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -27.54% | -5.14% |
| ROE (TTM) | -42.30% | 16.69% |
| Net Profit Margin (TTM) | N/A | -1,583.93% |
| ROIC 5YR AVG | -180.04% | 15.15% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8.62% | -389.24% | -1,067.41% |
| Revenue | N/A | -33.33% | -20.00% |
| Net Income | -22.75% | -1,170.98% | -712.81% |
| Cash Flow | -35.26% | -457,930.23% | -274,796.14% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 41.70 | 6.13 |
| Quick Ratio (TTM) | 41.70 | 5.85 |
| D/E Ratio (TTM) | 0.00 | -15.81 |
| Interest Coverage (TTM) | N/A | -1.57 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | 24.82 | 14.12 |
| LTL to 5YR AVG FCF | N/A | 0.17 |
| Shares Outstanding Growth 5YR AVG | 64.23% | 123.44% |